Readnour Robin Shane

Number of records: 4
SEC FilingCompany/StockTrade DateTransactionSharesAvg. PriceTotal% HoldingsGain/Loss
17-Jan-24 5:03 PM
View: 
An2 Therapeutics, Inc. (ANTX) 12-Jan-24Private Sale (Planned) 1,425$21.92$31,228.80(< 1%)
901.29K to 899.86K
12-Jan-24 5:08 PM
View: 
An2 Therapeutics, Inc. (ANTX) 10-Jan-24Private Sale (Planned) 3,669$21.93$80,443.20(< 1%)
904.96K to 901.29K
31-Mar-22 8:15 PM
View: 
An2 Therapeutics, Inc. (ANTX) 29-Mar-22Conversion 751,621----100%
0 to 751.62K
31-Mar-22 8:15 PM
View: 
An2 Therapeutics, Inc. (ANTX) 29-Mar-22Market Purchase 153,334$15.00$2,300,010.0020%
751.62K to 904.96K